Stand Alone Product Sample Clauses

Stand Alone Product. If TRAMS Software is licensed as a stand alone product to a third party (without enhancement by a non-TRAMS Software product which is licensed separately by CCS, hereinafter, "Stand Alone Product), royalty fee payable to CCNMS shall be equal to twenty percent (20%) of the Net Selling Price, subject to the following minimums: TRAMS SOFTWARE MODULES MINIMUM ROYALTY PAYMENT -------------------------------------------------------- -------------------------------------------------------- (a): TRAMS (including TRAMS/AG)......................... $40,000* (b): TRAMS/BC........................................... $50,000** (c): TRAMS/DE........................................... $5,000* (d): TRAMS/AG (without TRAMS)........................... No minimum twenty percent (20%) of the Net Selling Priceof TRAMS/AG * If sublicensed with another TRAMS module, the minimum fee for all TRAMS modules licensed in the aggregate to the same sublicensee shall not exceed $50,000. ** If TRAMS/BC is licensed to an existing TRAMS customer, then the Minimum Royalty Payment would be $ 10,000. 21
Sample 1
AutoNDA by SimpleDocs
Stand Alone Product. The Royalty Payment based on Net Selling Price due from CCS to CCNMS for each sublicense issued to a Service Bureau shall be computed based on the same terms and conditions described in Category 1 for Stand Alone Products. In addition, if the end-user license agreement provides for recurring fees based on either an account or transaction basis ("Recurring Fees"), then an additional Royalty Payment shall be due from CCS to CCNMS equal to twenty percent (20%) of the Recurring Fees; provided however, that the Recurring Fees on which the additional Royalty Payment is calculated shall not include any reasonable installation. support. training, maintenance, support software, changes, modifications or any other similar service.
Sample 1
Stand Alone Product. The Royalty payment shall be twenty percent (20%) of the actual Net Selling Price and shall not be subject to a Minimum Royalty Payment. (b)
Sample 1

Related to Stand Alone Product

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Combination Products If a LICENSED PRODUCT is sold to any third party in combination with other products, devices, components or materials that are capable of being sold separately and are not subject to royalties hereunder (“OTHER PRODUCTS,” with the combination of products being referred to as “COMBINATION PRODUCTS” and the Other Product and Licensed Product in such Combination Product being referred to as the “COMPONENTS”), the NET SALES of such LICENSED PRODUCT included in such COMBINATION PRODUCT shall be calculated by multiplying the NET SALES of the COMBINATION PRODUCT by the fraction A/(A+B), where A is the average NET SALES price of such LICENSED PRODUCT in the relevant country, as sold separately, and B is the total average NET SALES price of all OTHER PRODUCTS in the COMBINATION PRODUCT in the relevant country, as sold separately. If, in any country, any COMPONENT is not sold separately, NET SALES for royalty determination shall be determined by the formula [C / (C+D)], where C is the aggregate average fully absorbed cost of the Licensed Product components during the prior Royalty Period and D is the aggregate average fully absorbed cost of the other essential functional components during the prior Royalty Period, with such costs being determined in accordance with generally accepted accounting principles. To the extent that any SUBLICENSE INCOME relates to a COMBINATION PRODUCT or is otherwise calculated based on the value of one or more licenses or intellectual property rights held by the COMPANY, an AFFILIATE or SUBLICENSEE, COMPANY shall determine in good faith and report to THE PARTIES the share of such payments reasonably attributable to COMPANY’s or such AFFILIATE’s sublicense of the rights granted hereunder, based upon their relative importance and proprietary protection, which portion shall be the SUBLICENSE INCOME. THE PARTIES shall have the right to dispute such sharing determination in accordance with the dispute provisions of the AGREEMENT.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Combination Product The term “

  • Product The term “

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Territory The territorial limits of this Agreement shall be identical with those of the Reinsured Contracts.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!